These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38311425)

  • 1. The Early Onset of Levodopa-induced Dyskinesia in a Patient with Multiple System Atrophy.
    Okusa S; Nakahara J; Seki M
    Intern Med; 2024 Sep; 63(17):2451-2453. PubMed ID: 38311425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease.
    Hong JY; Sunwoo MK; Yoon JH; Kang SY; Sohn YH; Lee PH; Kim SH
    PLoS One; 2020; 15(8):e0237472. PubMed ID: 32817705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation.
    Li MH; Mestre TA; Fox SH; Taati B
    J Neuroeng Rehabil; 2018 Nov; 15(1):97. PubMed ID: 30400914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Long-Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test.
    Acharya M; Banerjee S; Chatterjee A; Mukherjee A; Biswas S; Gangopadhyay G; Biswas A
    Neurol India; 2021; 69(2):430-434. PubMed ID: 33904468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment.
    Thanvi B; Lo N; Robinson T
    Postgrad Med J; 2007 Jun; 83(980):384-8. PubMed ID: 17551069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia.
    Zhang YH; Tang BS; Song CY; Xu Q; Lou MX; Liu ZH; Yu RH; Yan XX; Guo JF
    Neurosci Lett; 2013 Nov; 556():109-12. PubMed ID: 24135335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia.
    Ueno SI; Oyama G; Kanai K; Hatano T; Shimo Y; Hattori N
    Tremor Other Hyperkinet Mov (N Y); 2020 Jun; 10():6. PubMed ID: 32775020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskinesia in multiple system atrophy and progressive supranuclear palsy.
    Jost WH; Lingor P; Tönges L; Schwarz J; Buhmann C; Kassubek J; Schrag A
    J Neural Transm (Vienna); 2019 Jul; 126(7):925-932. PubMed ID: 31087195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
    Zesiewicz TA; Sullivan KL; Hauser RA
    Curr Neurol Neurosci Rep; 2007 Jul; 7(4):302-10. PubMed ID: 17618536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predictive of the development of levodopa-induced dyskinesia and Wearing-Off in Parkinson's disease.
    Rajput AH
    Mov Disord; 2014 Mar; 29(3):429. PubMed ID: 24375668
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonia in multiple system atrophy.
    Boesch SM; Wenning GK; Ransmayr G; Poewe W
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):300-3. PubMed ID: 11861684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated assessment of levodopa-induced dyskinesia: Evaluating the responsiveness of video-based features.
    Li MH; Mestre TA; Fox SH; Taati B
    Parkinsonism Relat Disord; 2018 Aug; 53():42-45. PubMed ID: 29748112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning.
    Loo RTJ; Tsurkalenko O; Klucken J; Mangone G; Khoury F; Vidailhet M; Corvol JC; Krüger R; Glaab E;
    Parkinsonism Relat Disord; 2024 Sep; 126():107054. PubMed ID: 38991633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia.
    Suh DC; Pahwa R; Mallya U
    J Neurol Sci; 2012 Aug; 319(1-2):24-31. PubMed ID: 22664154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
    Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
    Warren Olanow C; Kieburtz K; Rascol O; Poewe W; Schapira AH; Emre M; Nissinen H; Leinonen M; Stocchi F;
    Mov Disord; 2013 Jul; 28(8):1064-71. PubMed ID: 23630119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the Side Onset of Parkinson's Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?
    Chung SJ; Yoo HS; Lee HS; Lee PH; Sohn YH
    J Parkinsons Dis; 2019; 9(1):241-247. PubMed ID: 30741690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.
    Santos-García D; de Deus T; Cores C; Feal Painceiras MJ; Íñiguez Alvarado MC; Samaniego LB; López Maside A; Jesús S; Cosgaya M; García Caldentey J; Caballol N; Legarda I; Hernández-Vara J; Cabo López I; López Manzanares L; González-Aramburu I; Ávila A; Gómez-Mayordomo V; Nogueira V; Dotor García-Soto J; Borrué-Fernández C; Solano B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Mendoza Z; Pareés I; Sánchez Alonso P; Alonso Losada MG; López-Ariztegui N; Gastón I; Kulisevsky J; Seijo M; Valero C; Alonso Redondo R; Buongiorno MT; Ordás C; Menéndez-González M; McAfee D; Martinez-Martin P; Mir P;
    Mov Disord Clin Pract; 2024 Jul; 11(7):830-849. PubMed ID: 38747234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating levodopa therapy for Parkinson's disease.
    Olanow CW; Kieburtz K; Stocchi F
    Mov Disord; 2014 Mar; 29(3):430. PubMed ID: 24408661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.